期刊
LETTERS IN DRUG DESIGN & DISCOVERY
卷 11, 期 3, 页码 249-255出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/15701808113106660082
关键词
Chagas' disease; Chalcones; Cruzain; Docking; Hydrazines; Molecular modeling
资金
- FAPESP [11/11499-0]
- CNPq
- CAPES
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/11499-0] Funding Source: FAPESP
Chagas disease is an infection caused by the intracellular protozoan Trypanosoma cruzi. It is estimated that more than 10 million people are infected, with 25 million living in areas at risk. The only drugs currently used in the therapy against this disease are nifurtimox and benznidazole; both, however, are only effective in the acute phase and also highly toxic. Therefore, the development of new drug candidates against this illness is of utmost importance. Cruzain, a cysteine protease involved in intracellular replication and differentiation of T. cruzi, has been selected as an attractive target for the development of new antitrypanosomal agents. In this context, compounds such as chalcones and hydrazides have presented a promising inhibitory activity against cruzain and hence are promising antichagasics. In this work we have applied molecular modeling methods and docking studies to evaluate the stereoeletronic properties of a series of compounds with cruzain inhibitory activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据